MarketsandMarkets Virtual Conference on Liquid Biopsy ( Time Zone - CENTRAL EUROPEAN TIME (CET)

20 -21 May 2020
CONFERENCE SPEAKERS
Speakers
Karl J. DSilva
Karl J. DSilva
Medical Director, Clinical Asst. Professor of Medicine,
Tufts University School of Medicine, Lahey Hospitals and Medical Center



Dana E. Connors
Dana E. Connors
Senior Scientific Project Manager,
Cancer Foundation for the National Institutes of Health



Emmanouil Karteris
Emmanouil Karteris
Head of CBCEL,
Brunel University London, UK


Dr Emmanouil Karteris is a Senior Lecturer at Brunel University London and Head of Cancer Biomarkers and Cellular Endocrinology Lab (www.cbcel.org). He gained his BSc degree in Medical Biochemistry (University of Surrey, 1995), MSc in Medical Genetics with Immunology (Brunel University 1996) and his PhD (Warwick University, 2000). Dr Karteris has published 72 research manuscripts (h-index: 26; i10-index:50) and has presented over 100 abstracts in leading international conferences. He also has expertise Intellectual Property (IP) law and in setting up clinical studies. His lab focuses in the characterisation and enumeration of circulating tumour cells using bioimaging techniques, as well as bioinformatic analyses using RNA-seq and measurements of circulating free DNA (cfDNA) and circulating tumour DNA (ctDNA) from liquid biopsies from a wide repertoire of tumours. His lab also investigates the role of endocrine disruptors in health and disease.


Antony Newton
Antony Newton
VP Business Development,
Inivata



DR CATHERINE ALIXPANABIÈRES PhD-
DR CATHERINE ALIXPANABIÈRES PhD-
Director of the Laboratory Rare Circulating Human Cells (LCCRH),
l’Université et CHU de Montpellier, France, Europe



Jennifer Whittington
Jennifer Whittington
Surgical Oncologist,
Queens Hospital Cancer Center



Dr. Harsha Doddihal
Dr. Harsha Doddihal
Clinical researcher, Oncologist,
Fortis Hospital



Youhe Gao
Youhe Gao
Professor Department of Biochemistry and Molecular Biology,
Beijing Normal University



IMEN EL AMOURI
IMEN EL AMOURI
Team Lead Liquid Biopsy Biobank,
Indivumed



Kevin Wang
Kevin Wang
Director, Program for Neuroproteomics and Biomarkers Research,
University of Florida


I am the Director of the Program for Neurotrauma, Neuroproteomics and Biomarkers Research and tenured Professor of Emergency Medicine, Neuroscience, Physiological Sciences   and Chemistry at the University of Florida in USA. I am also Research Health Neuroscientist, and Executive Committee Member of the Brain Rehabilitation Research Center, Malcom Randall VA Medical Center (Gainesville, FL). I have been involved as an a neurotrauma researcher since the late 1990’s. I have served as President and Council Member of the National Neurotrauma society, Board Member, Board of Governors of the International Brain Injury Association and Presidium Member of the Academy for Multidisciplinary Neurotraumatology. I am a co-founder of a biotechnology company Gryphon Bio, Inc. My research focus is translational research for biomarkers and therapies for traumatic brain injury (TBI), spinal cord injury, post-traumatic epilepsy, and chronic traumatic encephalopathy.  Two acute TBI blood-based protein biomarkers (UCH-L1/GFAP) that I co-discovered have received FDA clearance as the first in vitro diagnostic tests for detecting pathoanatomical lesions in TBI patients. I also hold leadership positions on various TBI initiatives such as International TBI Research Initiative (InTBIR), and multicenter TBI consortium studies (e.g. TRACK-TBI, CENTER-TBI, ICON-TBI). I am principle Investigator of multiple research grants funded by National Institute of Health, Department of Defense, Veterans Affairs and other research foundations. I have also authored over 300 peer-reviewed publications and edited /co-edited 5 scientific books.


JIANYU RAO, M.D
JIANYU RAO, M.D
Vice Chair- Diagnostic Technology Innovation, Director-Cytopathology, Director-International Telepathology Dept. Pathology and Lab Med, UCLA,
David Geffen School of Medicine